Preliminary observations on IGRA testing for TB infection in patients with severe COVID-19 eligible for immunosuppressive therapy
Open Access
- 1 December 2020
- journal article
- research article
- Published by Elsevier BV in Respiratory Medicine
- Vol. 175, 106204
- https://doi.org/10.1016/j.rmed.2020.106204
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, ChinaClinical Infectious Diseases, 2020
- Clinical characteristics of COVID-19 and active tuberculosis co-infection in an Italian reference hospitalEuropean Respiratory Journal, 2020
- Abnormal pulmonary function in COVID-19 patients at time of hospital dischargeEuropean Respiratory Journal, 2020
- Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 casesEuropean Respiratory Journal, 2020
- Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohortsPulmonology, 2020
- Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumoniaEmerging Microbes & Infections, 2020
- Frequency and significance of indeterminate and borderline Quantiferon Gold TB IGRA resultsEuropean Respiratory Journal, 2017
- IFN-γ Release Assay Result Is Associated with Disease Site and Death in Active TuberculosisAnnals of the American Thoracic Society, 2016
- Risk Assessment of Tuberculosis in Immunocompromised Patients. A TBNET StudyAmerican Journal of Respiratory and Critical Care Medicine, 2014
- Use of T-SPOT.TB in latent tuberculosis infection diagnosis in general and immunosuppressed populations.2007